Fusion Pharmaceuticals Inc
(FUSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-1999 | 12-1998 | 09-1998 | 06-1998 | 03-1998 | |
| Assets | |||||
| Current Assets | |||||
| Marketable Securities | 50 | 380 | 480 | 110 | 3,660 |
| Receivables | 3,420 | 4,840 | 5,280 | 6,000 | 5,080 |
| Inventories | 580 | 580 | 580 | 580 | 580 |
| Other current assets | 1,310 | 910 | 1,140 | 1,430 | 1,600 |
| TOTAL | $5,360 | $6,710 | $7,480 | $8,120 | $10,920 |
| Non-Current Assets | |||||
| Investments And Advances | 3,540 | 4,300 | 9,140 | 9,190 | 10,420 |
| Other Non-Current Assets | 970 | 990 | 2,260 | 2,260 | 2,260 |
| TOTAL | $4,510 | $5,290 | $11,400 | $11,450 | $12,680 |
| Total Assets | $12,750 | $15,150 | $22,150 | $23,000 | $26,710 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 280 | 620 | 340 | 450 | 570 |
| TOTAL | $6,340 | $7,200 | $6,740 | $6,470 | $6,120 |
| Non-Current Liabilities | |||||
| Long Term Debt | 50 | 60 | 120 | 160 | 180 |
| TOTAL | $50 | $60 | $120 | $160 | $180 |
| Total Liabilities | $6,390 | $7,260 | $6,870 | $6,630 | $6,310 |
| Shareholders' Equity | |||||
| Common Shares | 30 | 20 | 20 | 10 | 10 |
| Retained earnings | -51,390 | -49,570 | -41,500 | -38,680 | -26,650 |
| Other shareholders' equity | 210 | 220 | 2,100 | 3,600 | 380 |
| TOTAL | $6,360 | $7,880 | $15,280 | $16,360 | $20,390 |
| Total Liabilities And Equity | $12,750 | $15,140 | $22,150 | $22,990 | $26,700 |